Jiangzhong Pharma proposes $440m dividend, boosts stock plan

Jiangzhong Pharmaceutical (SSE:600750) announced its 2024 annual profit distribution plan, proposing a cash dividend of ¥0.70 per share, totaling approximately ¥440.31 million (approximately $44.03 million USD), representing 55.86% of the net profit attributable to shareholders. If combined with the interim dividend, the total cash dividend for 2024 is expected to reach ¥754.88 million, constituting approximately 95.77% of the net profit.